tiprankstipranks
ONO Pharmaceutical Co Ltd (OPHLF)
OTHER OTC:OPHLF

ONO Pharmaceutical Co (OPHLF) Stock Price & Analysis

14 Followers

OPHLF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$14.84 - $20.85
Previous Close$15.21
Volume1.40K
Average Volume (3M)4.07K
Market Cap
$7.14B
Enterprise Value$6.09B
Total Cash (Recent Filing)¥177.03B
Total Debt (Recent Filing)¥8.90B
Price to Earnings (P/E)8.2
Beta0.28
May 09, 2024
EPS EstimateN/A
Dividend Yield3.59%
Share Statistics
EPS (TTM)1.86
Shares Outstanding498,692,800
10 Day Avg. Volume3,087
30 Day Avg. Volume4,068
Standard Deviation0.13
R-Squared0.07
Alpha-0.00752
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

OPHLF FAQ

What was ONO Pharmaceutical Co Ltd’s price range in the past 12 months?
ONO Pharmaceutical Co Ltd lowest stock price was $14.84 and its highest was $20.85 in the past 12 months.
    What is ONO Pharmaceutical Co Ltd’s market cap?
    Currently, no data Available
    When is ONO Pharmaceutical Co Ltd’s upcoming earnings report date?
    ONO Pharmaceutical Co Ltd’s upcoming earnings report date is May 09, 2024 which is in 10 days.
      How were ONO Pharmaceutical Co Ltd’s earnings last quarter?
      Currently, no data Available
      Is ONO Pharmaceutical Co Ltd overvalued?
      According to Wall Street analysts ONO Pharmaceutical Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does ONO Pharmaceutical Co Ltd pay dividends?
        ONO Pharmaceutical Co Ltd pays a Annually dividend of $0.2 which represents an annual dividend yield of 3.59%. See more information on ONO Pharmaceutical Co Ltd dividends here
          What is ONO Pharmaceutical Co Ltd’s EPS estimate?
          ONO Pharmaceutical Co Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does ONO Pharmaceutical Co Ltd have?
          ONO Pharmaceutical Co Ltd has 498,692,800 shares outstanding.
            What happened to ONO Pharmaceutical Co Ltd’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of ONO Pharmaceutical Co Ltd?
            Currently, no hedge funds are holding shares in OPHLF
            ---

            ONO Pharmaceutical Co Stock Smart Score

            N/A
            Not Ranked
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Negative
            20 days / 200 days
            Momentum
            -26.62%
            12-Months-Change

            Fundamentals

            Return on Equity
            16.30%
            Trailing 12-Months
            Asset Growth
            0.49%
            Trailing 12-Months

            Company Description

            ONO Pharmaceutical Co Ltd

            Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Karyopharm Therapeutics
            Ligand Pharma
            BioMarin Pharmaceutical
            Alnylam Pharma
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis